McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

McKesson Ventures Announces Expansion Into Growth Equity and Welcomes Peter Lafer as Head of Growth Investing

by McKesson Ventures | Oct 16, 2025 | Media Coverage

In this newly created role, Peter will focus on building and leading a dedicated effort on investments in high-growth and profitable businesses. “We are thrilled to welcome Peter to the McKesson Ventures team,” said Dave Schulte, President of McKesson Ventures. “We...

Samsung Electronics Acquires Xealth, Bridging The Gap Between Wellness and Medical Care

by McKesson Ventures | Jul 11, 2025 | Press Releases

On Tuesday, July 8th, digital healthcare integration provider and McKesson Ventures portfolio company Xealth announced that it had been acquired by Samsung Electronics Co, Ltd. The acquisition seeks to combine Samsung’s innovative wearable technology with Xealth’s...

Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada

by McKesson Ventures | Apr 28, 2025 | Press Releases

On Monday, April 28th, clinical real-world data (RWD) company Atropos Health announced that it would be collaborating with community oncology real-world data (RWD) provider Ontada to enhance oncology data use cases for clinicians, researchers, and healthcare leaders —...

Merck Announces the Launch of the Merck Digital Sciences Studio to Help Healthcare Startups Quickly Bring their Innovations to Market

by McKesson Ventures | Jun 29, 2022 | Media Coverage, Press Releases

Merck, known as MSD outside the U.S. and Canada, has announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct...

McKesson Ventures Takes the ParityPledge to Commit to Increasing Representation for Women and People of Color

by McKesson Ventures | Jun 17, 2022 | Press Releases

McKesson Ventures has signed the Parity.org ParityPledge® in Support of People of Color and in Support of Women. The ParityPledge simply asks that companies commit to interview and consider at least one qualified woman and person of color for every open role, VP and...
Page 1 of 1012345...10...»Last »

Recent Posts

  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
  • Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
  • Reimagine Care and Tampa General Hospital Cancer Institute Launch Virtual Cancer Care Collaboration to Reduce Hospitalizations and Elevate Patient Support
  • Midi Health CEO Joanna Strober Discusses Accessible Menopause Care with McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
  • Atropos Health Launches the Atropos Evidence™ Agent with Microsoft Teams to Surface Personalized Evidence during Multidisciplinary Care Team Collaborations
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

 

Contact Us

In the News

Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking

Reimagine Care and Tampa General Hospital Cancer Institute Launch Virtual Cancer Care Collaboration to Reduce Hospitalizations and Elevate Patient Support

Midi Health CEO Joanna Strober Discusses Accessible Menopause Care with McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
  • Follow